Outlook 2024
Annual Industry Ranking And Forecast
VIEW NOWHBW Insight is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183
Printed By
Views from industry leaders and experts on the biggest trends, challenges and opportunities facing consumer health in the new year.
The negotiated revision of the Classification, Labeling and Packaging (CLP) regulation met with industry approval in April, even if it just kicks the can down the road with regard to classification of more-than-one-constituent substances (MOCS). DSM-Firmenich announces partnerships with plants in mind, Symrise’s new CEO maintains growth targets, and more news in brief.
Michael Creaturo’s petition isn’t the first suggestion made to FDA and industry that there’s room for improvement in labeling for children’s doses of some OTC formulations. Creaturo's petition comes after he received a US patent in December 2022 for an “integrated container and dosing device for liquid medication delivery.”
DEA NPRM to move marijuana from CSA Schedule I to Schedule III says synthetically derived THC “is outside the CSA’s definition of marijuana” and “will remain in Schedule I.” Synthetically derived THC includes copies of ingredients derived from cannabis plants which qualify as hemp by containing no more than 0.3% delta-9 THC concentration by dry weight and are common in supplements and food available in US.
A survey of 1,000 EU health consumers commissioned by AESGP finds that OTC users see numerous benefits of digital patient information leaflets, but are agreed that information should also continue to be available in paper form.
Kailo models gut and mental health link; AdvoCare has first female CEO; EyePromise enlists athletes across sports; Edelman catches One A Day message; Ronaldo wears Whoop, also invests; and Jarrow adds “Chief of Superior Starts.”
A survey of 1,000 EU health consumers commissioned by AESGP finds that OTC users see numerous benefits of digital patient information leaflets, but are agreed that information should also continue to be available in paper form.
Plezi also announces launches “PLEZi FiZZ” carbonated fruit drink with 70% less sugar than the same amount of leading soft drinks, no added sugar, plus 2g fiber, vitamin C and other nutrients. With 10% of profits going to children’s health initiatives, its initial donation was $1m to FoodCorps' Nourishing Futures.
Court ruling that state’s restrictions “may very well regulate protected speech”’ allows CRN “to move forward on the merits of the case,” says CEO Steve Mister. CRN’s allegations “plausibly support the inference that the [restriction] might very well regulate protected speech,” judge writes.
The negotiated revision of the Classification, Labeling and Packaging (CLP) regulation met with industry approval in April, even if it just kicks the can down the road with regard to classification of more-than-one-constituent substances (MOCS). DSM-Firmenich announces partnerships with plants in mind, Symrise’s new CEO maintains growth targets, and more news in brief.
A survey of 1,000 EU health consumers commissioned by AESGP finds that OTC users see numerous benefits of digital patient information leaflets, but are agreed that information should also continue to be available in paper form.
Herbal and nutritional supplement direct seller has reached 85% solar power use at its US facilities while also reducing landfill waste from those sites more than 90%, cutting its US shipping routes by half and consolidating four distribution centers in Europe into one operating on wind power.
In this episode of the updated Over The Counter podcast, HBW Insight speaks to sustainable packaging expert Tony Perrotta about the complexities of replacing plastic pill packs in medicines packaging. Perrotta is a partner at PA Consulting, which set up the Blister Pack Collective alongside consumer health players Haleon, Bayer and Sanofi. They are working with PulPac, which has invented a dry molded fiber alternative to plastic, which the Collective hopes to commercialize within 12-24 months. We discuss whether regulators will accept such alternatives, given the safety and stability requirements for medicines, and the challenges of recycling, given the multitude of different frameworks and processes across the world. Perrotta also reveals that one of the partners in PA Consulting’s Bottle Collective, which hopes to replace plastic bottles in the food, personal care and consumer health industries, will soon launch its first market trial.
Focus and persistence are the keys to successful brand and company growth, according to TheOTCLab's founder and CEO Albert Swane, speaking to HBW Insight's Over The Counter podcast.
In this episode of the updated Over The Counter podcast, HBW Insight speaks to sustainable packaging expert Tony Perrotta about the complexities of replacing plastic pill packs in medicines packaging. Perrotta is a partner at PA Consulting, which set up the Blister Pack Collective alongside consumer health players Haleon, Bayer and Sanofi. They are working with PulPac, which has invented a dry molded fiber alternative to plastic, which the Collective hopes to commercialize within 12-24 months. We discuss whether regulators will accept such alternatives, given the safety and stability requirements for medicines, and the challenges of recycling, given the multitude of different frameworks and processes across the world. Perrotta also reveals that one of the partners in PA Consulting’s Bottle Collective, which hopes to replace plastic bottles in the food, personal care and consumer health industries, will soon launch its first market trial.
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
“Consumers are rewriting the rules when it comes to where they are going for information and the type of information they are looking for,” reports Kaizo’s Anita Nahal, speaking to HBW Insight’s Over the Counter podcast about the agency’s latest Communicating Health Messages report. Trust in social media has increased, and personal beliefs and lived experiences are playing a larger role in shaping attitudes to health information, explains Nahal, who is director at the London-based PR agency. However, consumers are also continuing to “tune-out” from health messages and be less critical of sources. To help consumers navigate this new reality, consumer health companies need to adapt, rethink and reset their communication strategies, Nahal advises.
The negotiated revision of the Classification, Labeling and Packaging (CLP) regulation met with industry approval in April, even if it just kicks the can down the road with regard to classification of more-than-one-constituent substances (MOCS). DSM-Firmenich announces partnerships with plants in mind, Symrise’s new CEO maintains growth targets, and more news in brief.
Michael Creaturo’s petition isn’t the first suggestion made to FDA and industry that there’s room for improvement in labeling for children’s doses of some OTC formulations. Creaturo's petition comes after he received a US patent in December 2022 for an “integrated container and dosing device for liquid medication delivery.”
Focus and persistence are the keys to successful brand and company growth, according to TheOTCLab's founder and CEO Albert Swane, speaking to HBW Insight's Over The Counter podcast.
DEA NPRM to move marijuana from CSA Schedule I to Schedule III says synthetically derived THC “is outside the CSA’s definition of marijuana” and “will remain in Schedule I.” Synthetically derived THC includes copies of ingredients derived from cannabis plants which qualify as hemp by containing no more than 0.3% delta-9 THC concentration by dry weight and are common in supplements and food available in US.
Procter & Gamble will feature more than 30 of its brands in Paris 2024 Olympic and Paralympic Games-inspired campaigns spotlighting “Everyday Champions” in its portfolio.
Kailo models gut and mental health link; AdvoCare has first female CEO; EyePromise enlists athletes across sports; Edelman catches One A Day message; Ronaldo wears Whoop, also invests; and Jarrow adds “Chief of Superior Starts.”
Headwinds for the Russian ruble and Turkish lira held back growth at Recordati's OTC business in the first quarter of 2024.
A survey of 1,000 EU health consumers commissioned by AESGP finds that OTC users see numerous benefits of digital patient information leaflets, but are agreed that information should also continue to be available in paper form.
Aimed at curbing so-called "Sephora kids" purchases of anti-aging cosmetic products, a California bill would prohibit sale of skin-care products or cosmetics containing retinol or AHAs to consumers under age 13.
Plezi also announces launches “PLEZi FiZZ” carbonated fruit drink with 70% less sugar than the same amount of leading soft drinks, no added sugar, plus 2g fiber, vitamin C and other nutrients. With 10% of profits going to children’s health initiatives, its initial donation was $1m to FoodCorps' Nourishing Futures.
Bayer Consumer Health is focused on driving up consumption, particularly in the US, following a slow start to 2024. New president Julio Triana says he feels confident for the remainder of the year with the business in good shape.
Herbal and nutritional supplement direct seller has reached 85% solar power use at its US facilities while also reducing landfill waste from those sites more than 90%, cutting its US shipping routes by half and consolidating four distribution centers in Europe into one operating on wind power.
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.